This announcement is a separate document:
昭衍新药关于调整2021年A股限制性股票激励计划授予权益数量及回购价格的公告
Announcement of Zhaoyan New Pharmaceutical on the adjustment of the number of benefits granted by the 2021 A-share Restricted Stock Incentive Plan and the repurchase price
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.